Investor Relations

You are here

The Investor Relations department represents MorphoSys and its equity story to the financial market and supports the Company's overall strategic communication. Through active, reliable and transparent investor relations work, the aim is to enable MorphoSys's investors to make a realistic assessment of the Company.


28/07/2021
MorphoSys AG Reports Second Quarter and First Half 2021 Results
26/07/2021
Ad-hoc: MorphoSys AG to update financial guidance for 2021 and reduce...
21/07/2021
Invitation to MorphoSys' Second Quarter and First Half 2021 Results...


Tue
31
'21
Aug

Commerzbank Corporate Conference 2021

virtual
Wed
22
'21
Sep

10th Baader Investment Conference

virtuell
Wed
10
'21
Nov

Third Quarter Interim Statement 2021

Date
Title
Add to Calendar
  1. 03/15/2021

    Year-End Results 2020

  2. 05/05/2021

    First Quarter Interim Statement 2021

  3. 05/19/2021

    Annual General Meeting 2021

  4. 07/28/2021

    Half-Year Report 2021

  5. 11/10/2021

    Third Quarter Interim Statement 2021


Annual General Meeting



Investor Contact

Dr. Julia Neugebauer

Senior Director Investor Relations

Phone: +49 89 89927 179

Email Contact
LinkedIn-Profile

Myles Clouston

Senior Director, Head of US Investor Relations

Phone: +1 857 772 0240

Email Contact